Data Coverage Methodology Platform Capabilities
Indication Coverage by Therapy Area

Interactive breakdown of our epidemiological database

Oncology
64+ Indications
Non-Oncology
120+ Indications
Rare/Orphan Diseases
42+ Indications

226+

Total Indications Covered

Continuously expanding our epidemiological database

Global Market Coverage

Worldwide epidemiological intelligence across major healthcare markets

Global Coverage

Epidemiological data accross continents

G8 18.18%
China France Germany Italy Japan Spain United Kingdom United States of America
North America 2.27%
Canada
Europe 27.27%
Austria Belgium Denmark Finland Greece Netherlands Norway Poland Portugal Russia Sweden Switzerland
South / Latin America 11.36%
Argentina Chile Colombia Mexico Peru
Middle East 6.82%
Kuwait Saudi Arabia United Arab Emirates
Asia Pacific 25%
Australia Hong Kong India Indonesia Malaysia New Zealand Philippines Singapore Taiwan Thailand Vietnam
Africa 9.09%
Egypt Morocco Nigeria South Africa
EU5 11.36%
France Germany Italy Spain United Kingdom
G7 15.91%
France Germany Italy Japan Spain United Kingdom United States of America

56+

Countries Covered

Major healthcare markets with reliable epidemiological data

Platform Growth & Expansion Journey

Our continuous expansion across indications and markets

120
Current Indications
50
Current Markets
Insights Coverage

Comprehensive insights across all epidemiological domains

Epidemiology
Incidence (N, %)
New cases per population with temporal trends
Prevalence (N, %)
Total disease burden in target populations
Diagnosed (N, %)
Confirmed diagnosed patient counts
Stage & Phases (N, %)
Patient distribution across disease stages
Treated Cases
Patients receiving active treatment
Patient Segmentation
By age, sex, severity, stage (N, %)
Survival (N, %)
Overall and progression-free survival rates
Comorbidities (N, %)
Associated health conditions prevalence
Historic and Forecast Data
Trends with CAGR analysis
Disease Overview
Definition
Comprehensive disease definitions and terminology
Classification
Disease taxonomy and ICD coding systems
Risk Factors and Symptoms
Clinical manifestations and risk assessment
Pathophysiology
Disease mechanisms and biological pathways
Screening and Diagnosis
Diagnostic criteria and testing methods
Current Therapies
Treatment Goals
Primary and secondary therapeutic endpoints
Key Drug Classes
Major therapeutic categories and mechanisms
Approved Drugs/Off-Label Drugs
Regulatory status and usage patterns
Approval History
Timeline of regulatory approvals
Dosing/Regimens
Administration protocols and schedules
Treatment Pathways
Standard care algorithms and guidelines
Efficacy/Safety Benchmarks
Performance standards and outcomes
Key Unmet Needs
Gaps in current treatment paradigms
KOL Insights
Expert opinions and clinical perspectives
Drug Utilization
Market Share Analysis
Competitive landscape breakdown by therapy
Prescription Patterns
Physician prescribing behavior analysis
Patient Flow Analysis
Treatment journey and pathway mapping
Switching Patterns
Therapy transition and discontinuation analysis
Adherence Rates
Patient compliance and persistence metrics
Cost-Effectiveness
Economic impact and budget analysis

Ready to Transform Your Epidemiological Research?

Join industry leaders who trust Epi Lansis for comprehensive pharmaceutical analytics and insights

5500+
Expert Interviews
120+
Indications Covered
50+
Countries Served
Start Free Trial
No credit card required • 14-day free trial • Cancel anytime